{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:21:57Z","timestamp":1782829317486,"version":"3.54.5"},"reference-count":149,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701600"],"award-info":[{"award-number":["81701600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ17H100001"],"award-info":[{"award-number":["LQ17H100001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF18H100001"],"award-info":[{"award-number":["LGF18H100001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Medical and Health Program of Zhejiang Province","award":["2019RC032"],"award-info":[{"award-number":["2019RC032"]}]},{"name":"Task of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic erythematosus lupus (SLE) is a classic autoimmune disease characterized by multiple autoantibodies and immune-mediated tissue damage. The aetiology of this disease is still unclear. A new drug, belimumab, which acts against the B-lymphocyte stimulator (BLyS), can effectively improve the condition of SLE patients, but it cannot resolve all SLE symptoms. The discovery of novel, precise therapeutic targets is urgently needed. It is well known that abnormal T-cell function is one of the most crucial factors contributing to the pathogenesis of SLE. Protein post-translational modifications (PTMs), including phosphorylation, glycosylation, acetylation, methylation, ubiquitination and SUMOylation have been emphasized for their roles in activating protein activity, maintaining structural stability, regulating protein\u2013protein interactions and mediating signalling pathways, in addition to other biological functions. Summarizing the latest data in this area, this review focuses on the potential roles of diverse PTMs in regulating T-cell function and signalling pathways in SLE pathogenesis, with the goal of identifying new targets for SLE therapy.<\/jats:p>","DOI":"10.1093\/rheumatology\/keab095","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T21:02:56Z","timestamp":1611608576000},"page":"2502-2516","source":"Crossref","is-referenced-by-count":12,"title":["Post-translational modifications in T cells in systemic erythematosus lupus"],"prefix":"10.1093","volume":"60","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-0723","authenticated-orcid":false,"given":"Jin","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-7841","authenticated-orcid":false,"given":"Weiqian","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"2021100507420738100_keab095-B1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3899\/jrheum.171290","article-title":"Role of MiR-98 and its underlying mechanisms in systemic lupus erythematosus","volume":"45","author":"Xie","year":"2018","journal-title":"J Rheumatol"},{"key":"2021100507420738100_keab095-B2","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crispin","year":"2008","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B3","author":"Firestein","year":"2013"},{"key":"2021100507420738100_keab095-B4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0090-1229(92)90009-D","article-title":"Impaired generation of polyclonal T cell-mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus","volume":"63","author":"Stohl","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"2021100507420738100_keab095-B5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/keg081","article-title":"Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus","volume":"42","author":"Yasutomo","year":"2003","journal-title":"Rheumatology"},{"key":"2021100507420738100_keab095-B6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2014.10.004","article-title":"Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage","volume":"31","author":"Dai","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"2021100507420738100_keab095-B7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI118855","article-title":"Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes","volume":"98","author":"Koshy","year":"1996","journal-title":"J Clin Invest"},{"key":"2021100507420738100_keab095-B8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.25032","article-title":"Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus","volume":"62","author":"Simpson","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00296-010-1771-0","article-title":"Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis","volume":"32","author":"Xing","year":"2012","journal-title":"Rheumatol Int"},{"key":"2021100507420738100_keab095-B11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fimmu.2015.00610","article-title":"Disturbed T cell signaling and altered Th17 and regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus","volume":"6","author":"Rother","year":"2015","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B12","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3389\/fimmu.2018.01793","article-title":"Follicular helper T cells in systemic lupus erythematosus","volume":"9","author":"Kim","year":"2018","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B13","doi-asserted-by":"crossref","first-page":"e130062","DOI":"10.1172\/jci.insight.130062","article-title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","volume":"4","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight"},{"key":"2021100507420738100_keab095-B14","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/rheumatology\/kez228","article-title":"1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus","volume":"58","author":"Lin","year":"2019","journal-title":"Rheumatology"},{"key":"2021100507420738100_keab095-B15","first-page":"1861","article-title":"Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation","volume":"58","author":"Makiyama","year":"2019","journal-title":"Rheumatology"},{"key":"2021100507420738100_keab095-B16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4049\/jimmunol.163.3.1682","article-title":"Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression","volume":"163","author":"Wong","year":"1999","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B17","doi-asserted-by":"crossref","first-page":"740619","DOI":"10.1155\/2010\/740619","article-title":"The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity","volume":"2010","author":"Lieberman","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"2021100507420738100_keab095-B18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/ar414","article-title":"The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases","volume":"4","author":"Horwitz","year":"2002","journal-title":"Arthritis Res"},{"key":"2021100507420738100_keab095-B19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1196\/annals.1313.013","article-title":"Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation","volume":"1050","author":"Filaci","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"2021100507420738100_keab095-B20","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.4049\/jimmunol.166.10.6452","article-title":"Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus","volume":"166","author":"Filaci","year":"2001","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/art.1780330823","article-title":"CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis","volume":"33","author":"Linker-Israeli","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B22","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/art.10432","article-title":"T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis","volume":"46","author":"Murata","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B23","doi-asserted-by":"crossref","first-page":"108602","DOI":"10.1016\/j.clim.2020.108602","article-title":"Immunophenotyping reveals distinct subgroups of lupus patients based on their activated T cell subsets","volume":"221","author":"Perry","year":"2020","journal-title":"Clin Immunol"},{"key":"2021100507420738100_keab095-B24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.semarthrit.2018.01.001","article-title":"Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus","volume":"48","author":"Oon","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2021100507420738100_keab095-B25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nsmb.1842","article-title":"Post-translational modifications in signal integration","volume":"17","author":"Deribe","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"2021100507420738100_keab095-B26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","article-title":"Post-translational modification control of innate immunity","volume":"45","author":"Liu","year":"2016","journal-title":"Immunity"},{"key":"2021100507420738100_keab095-B27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/ijms19030819","article-title":"Regulation of T-cell signaling by post-translational modifications in autoimmune disease","volume":"19","author":"Kuwabara","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2021100507420738100_keab095-B28","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1073\/pnas.87.5.1978","article-title":"Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus","volume":"87","author":"Hasler","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021100507420738100_keab095-B29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1172\/JCI117340","article-title":"Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes","volume":"94","author":"Kammer","year":"1994","journal-title":"J Clin Invest"},{"key":"2021100507420738100_keab095-B30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2249.1997.4371334.x","article-title":"Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE)","volume":"109","author":"Takeuchi","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2021100507420738100_keab095-B31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2015.00051","article-title":"Down regulation of the TCR complex CD3\u03b6-chain on CD3+ T cells: a potential mechanism for helminth-mediated immune modulation","volume":"6","author":"Appleby","year":"2015","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1172\/JCI1457","article-title":"Altered pattern of TCR\/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain","volume":"101","author":"Liossis","year":"1998","journal-title":"J Clin Invest"},{"key":"2021100507420738100_keab095-B33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2249.2002.01833.x","article-title":"Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients","volume":"129","author":"Pang","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2021100507420738100_keab095-B34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(200201)46:1<163::AID-ART10065>3.0.CO;2-J","article-title":"Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus","volume":"46","author":"Nambiar","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B35","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.4049\/jimmunol.169.10.6048","article-title":"Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus","volume":"169","author":"Juang","year":"2002","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B36","doi-asserted-by":"crossref","first-page":"16126","DOI":"10.1074\/jbc.274.23.16126","article-title":"A potential role for Elf-1 in CD4 promoter function","volume":"274","author":"Sarafova","year":"1999","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B37","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1002\/j.1460-2075.1996.tb00947.x","article-title":"An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein","volume":"15","author":"John","year":"1996","journal-title":"EMBO J"},{"key":"2021100507420738100_keab095-B38","first-page":"1153","article-title":"Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors","volume":"14","author":"Wang","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2021100507420738100_keab095-B39","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4049\/jimmunol.168.6.2865","article-title":"Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain","volume":"168","author":"Juang","year":"2002","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2003.tb06054.x","article-title":"Activation of the Ets transcription factor Elf-1 requires phosphorylation and glycosylation: defective expression of activated Elf-1 is involved in the decreased TCR zeta chain gene expression in patients with systemic lupus erythematosus","volume":"987","author":"Tsokos","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"2021100507420738100_keab095-B41","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.4049\/jimmunol.181.5.3658","article-title":"PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells","volume":"181","author":"Juang","year":"2008","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B42","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1074\/jbc.M110.166785","article-title":"Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus","volume":"286","author":"Juang","year":"2011","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B43","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203306069985","article-title":"CAMP response element modulator a expression in patients with systemic lupus erythematosus","volume":"15","author":"Kyttaris","year":"2006","journal-title":"Lupus"},{"key":"2021100507420738100_keab095-B44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0049-0172(96)80018-7","article-title":"Immunopathogenesis and spectrum of infections in systemic lupus erythematosus","volume":"25","author":"Iliopoulos","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"2021100507420738100_keab095-B45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jmb.2006.09.036","article-title":"Increased chromatin association of Sp1 in interphase cells by PP2A-mediated dephosphorylations","volume":"364","author":"Vicart","year":"2006","journal-title":"J Mol Biol"},{"key":"2021100507420738100_keab095-B46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1074-7613(00)80606-8","article-title":"LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation","volume":"9","author":"Zhang","year":"1998","journal-title":"Immunity"},{"key":"2021100507420738100_keab095-B47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clim.2011.12.010","article-title":"Linker for activation of T cells is displaced from lipid rafts and decreases in lupus T cells after activation via the TCR\/CD3 pathway","volume":"142","author":"Abdoel","year":"2012","journal-title":"Clin Immunol"},{"key":"2021100507420738100_keab095-B48","doi-asserted-by":"crossref","first-page":"22050","DOI":"10.1073\/pnas.1016184107","article-title":"Palmitoylation regulates raft affinity for the majority of integral raft proteins","volume":"107","author":"Levental","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021100507420738100_keab095-B49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0961203314556139","article-title":"T cells as a therapeutic target in SLE","volume":"24","author":"Comte","year":"2015","journal-title":"Lupus"},{"key":"2021100507420738100_keab095-B50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2011.04505.x","article-title":"Immune complexes and late complement proteins trigger activation of Syk tyrosine kinase in human CD4(+) T cells","volume":"167","author":"Chauhan","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"2021100507420738100_keab095-B51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fimmu.2016.00078","article-title":"Targeting Syk in autoimmune rheumatic diseases","volume":"7","author":"Deng","year":"2016","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2018.04.007","article-title":"The role of Syk in peripheral T cells","volume":"192","author":"Park","year":"2018","journal-title":"Clin Immunol"},{"key":"2021100507420738100_keab095-B53","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/art.33375","article-title":"CREMalpha suppresses spleen tyrosine kinase expression in normal but not systemic lupus erythematosus T cells","volume":"64","author":"Ghosh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1096\/fasebj.12.03.299","article-title":"Translational control: a general mechanism for gene regulation during T cell activation","volume":"12","author":"Garcia-Sanz","year":"1998","journal-title":"FASEB J"},{"key":"2021100507420738100_keab095-B55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1432-1033.1996.00747.x","article-title":"Initiation of protein synthesis in eukaryotic cells","volume":"236","author":"Pain","year":"1996","journal-title":"Eur J Biochem"},{"key":"2021100507420738100_keab095-B56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1357-2725(98)00128-9","article-title":"Eukaryotic initiation factor eIF2","volume":"31","author":"Kimball","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"2021100507420738100_keab095-B57","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1096\/fasebj.10.12.8903508","article-title":"The eIF-2alpha kinases and the control of protein synthesis","volume":"10","author":"de Haro","year":"1996","journal-title":"FASEB J"},{"key":"2021100507420738100_keab095-B58","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1172\/JCI9352","article-title":"Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients","volume":"106","author":"Grolleau","year":"2000","journal-title":"J Clin Invest"},{"key":"2021100507420738100_keab095-B59","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"2021100507420738100_keab095-B60","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4161\/cc.8.17.9446","article-title":"Abnormal activation of the Akt-GSK3beta signaling pathway in peripheral blood T cells from patients with systemic lupus erythematosus","volume":"8","author":"Tang","year":"2009","journal-title":"Cell Cycle"},{"key":"2021100507420738100_keab095-B61","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.178.3.1938","article-title":"Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0968-0004(96)10071-2","article-title":"ERM proteins: head-to-tail regulation of actin-plasma membrane interaction","volume":"22","author":"Tsukita","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"2021100507420738100_keab095-B63","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00418-004-0648-2","article-title":"Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing","volume":"121","author":"Jensen","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"2021100507420738100_keab095-B64","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1083\/jcb.140.3.647","article-title":"Rho-kinase phosphorylates COOH-terminal threonines of ezrin\/radixin\/moesin (ERM) proteins and regulates their head-to-tail association","volume":"140","author":"Matsui","year":"1998","journal-title":"J Cell Biol"},{"key":"2021100507420738100_keab095-B65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0090-1229(91)90065-I","article-title":"A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus","volume":"60","author":"Tada","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"2021100507420738100_keab095-B66","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"2021100507420738100_keab095-B67","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1172\/JCI78087","article-title":"T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity","volume":"125","author":"Moulton","year":"2015","journal-title":"J Clin Invest"},{"key":"2021100507420738100_keab095-B68","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.immuni.2012.08.014","article-title":"Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis","volume":"37","author":"Pisitkun","year":"2012","journal-title":"Immunity"},{"key":"2021100507420738100_keab095-B69","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/08820139.2018.1458105","article-title":"Upregulated IL-1 receptor-associated kinase 1 (IRAK1) in systemic lupus erythematosus: IRAK1 inhibition represses Th17 differentiation with therapeutic potential","volume":"47","author":"Zhou","year":"2018","journal-title":"Immunol Invest"},{"key":"2021100507420738100_keab095-B70","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","article-title":"The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling","volume":"80","author":"Flannery","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"2021100507420738100_keab095-B71","doi-asserted-by":"crossref","first-page":"51697","DOI":"10.1074\/jbc.M410369200","article-title":"IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression","volume":"279","author":"Huang","year":"2004","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B72","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","article-title":"Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation","volume":"82","author":"Wen","year":"1995","journal-title":"Cell"},{"key":"2021100507420738100_keab095-B74","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.cellsig.2014.04.003","article-title":"Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells","volume":"26","author":"Mandal","year":"2014","journal-title":"Cell Signal"},{"key":"2021100507420738100_keab095-B75","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/onc.2010.63","article-title":"Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1\/2, and ERK1\/2)","volume":"29","author":"Aziz","year":"2010","journal-title":"Oncogene"},{"key":"2021100507420738100_keab095-B76","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"2021100507420738100_keab095-B77","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"2021100507420738100_keab095-B78","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1096\/fj.201900105RR","article-title":"AhR-ROR-gammat complex is a therapeutic target for MAP4K3\/GLK(high)IL-17A(high) subpopulation of systemic lupus erythematosus","volume":"33","author":"Chuang","year":"2019","journal-title":"FASEB J"},{"key":"2021100507420738100_keab095-B79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cellimm.2009.03.016","article-title":"Defects of mitogen-activated protein kinase in ICOS signaling pathway lead to CD4(+) and CD8(+) T-cell dysfunction in patients with active SLE","volume":"258","author":"Gang","year":"2009","journal-title":"Cell Immunol"},{"key":"2021100507420738100_keab095-B80","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1016\/j.cub.2019.01.003","article-title":"Protein glycosylation","volume":"29","author":"Eichler","year":"2019","journal-title":"Curr Biol"},{"key":"2021100507420738100_keab095-B81","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/19420862.2019.1630218","article-title":"Site-specific N- and O-glycosylation analysis of atacicept","volume":"11","author":"Stavenhagen","year":"2019","journal-title":"MAbs"},{"key":"2021100507420738100_keab095-B82","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0092-8674(01)00277-X","article-title":"Glycosylation, immunity, and autoimmunity","volume":"104","author":"Lowe","year":"2001","journal-title":"Cell"},{"key":"2021100507420738100_keab095-B83","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/jmbi.1999.3104","article-title":"Roles for glycosylation of cell surface receptors involved in cellular immune recognition","volume":"293","author":"Rudd","year":"1999","journal-title":"J Mol Biol"},{"key":"2021100507420738100_keab095-B84","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1126\/science.291.5512.2370","article-title":"Glycosylation and the immune system","volume":"291","author":"Rudd","year":"2001","journal-title":"Science"},{"key":"2021100507420738100_keab095-B85","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.celrep.2017.07.027","article-title":"Blockage of core fucosylation reduces cell-surface expression of PD-1 and promotes anti-tumor immune responses of T cells","volume":"20","author":"Okada","year":"2017","journal-title":"Cell Rep"},{"key":"2021100507420738100_keab095-B86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fimmu.2018.00078","article-title":"Core fucosylation of the T cell receptor is required for T cell activation","volume":"9","author":"Liang","year":"2018","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B87","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1039\/C6OB00586A","article-title":"Substrate specificity of FUT8 and chemoenzymatic synthesis of core-fucosylated asymmetric N-glycans","volume":"14","author":"Calderon","year":"2016","journal-title":"Org Biomol Chem"},{"key":"2021100507420738100_keab095-B88","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1189\/jlb.2VMA0915-432RR","article-title":"Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses","volume":"99","author":"Hauser","year":"2016","journal-title":"J Leukoc Biol"},{"key":"2021100507420738100_keab095-B89","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nat Immunol"},{"key":"2021100507420738100_keab095-B90","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.3390\/ijms20184455","article-title":"Altered cell surface N-glycosylation of resting and activated T cells in systemic lupus erythematosus","volume":"20","author":"Szab\u00f3","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2021100507420738100_keab095-B91","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"2021100507420738100_keab095-B92","doi-asserted-by":"crossref","first-page":"17122","DOI":"10.1074\/jbc.M000300200","article-title":"The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies","volume":"275","author":"Brahms","year":"2000","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B93","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.4049\/jimmunol.171.6.2840","article-title":"A failure to repair self-proteins leads to T cell hyperproliferation and autoantibody production","volume":"171","author":"Doyle","year":"2003","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B94","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.4049\/jimmunol.177.7.4541","article-title":"Intracellular protein modification associated with altered T cell functions in autoimmunity","volume":"177","author":"Yang","year":"2006","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08916934.2012.732133","article-title":"Lupus autoimmunity altered by cellular methylation metabolism","volume":"46","author":"Yang","year":"2013","journal-title":"Autoimmunity"},{"key":"2021100507420738100_keab095-B96","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(01)00269-0","article-title":"Arginine methylation of STAT1 modulates IFNalpha\/beta-induced transcription","volume":"104","author":"Mowen","year":"2001","journal-title":"Cell"},{"key":"2021100507420738100_keab095-B97","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20040373","article-title":"Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5)","volume":"388","author":"Richard","year":"2005","journal-title":"Biochem J"},{"key":"2021100507420738100_keab095-B98","doi-asserted-by":"crossref","first-page":"48938","DOI":"10.18632\/oncotarget.16894","article-title":"Histone demethylase JMJD3 regulates CD11a expression through changes in histone H3K27 tri-methylation levels in CD4+ T cells of patients with systemic lupus erythematosus","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget"},{"key":"2021100507420738100_keab095-B99","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/cr.2007.83","article-title":"JMJD3 is a histone H3K27 demethylase","volume":"17","author":"Xiang","year":"2007","journal-title":"Cell Res"},{"key":"2021100507420738100_keab095-B100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2010.02.002","article-title":"Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells","volume":"35","author":"Zhao","year":"2010","journal-title":"J Autoimmun"},{"key":"2021100507420738100_keab095-B101","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood.V99.12.4503","article-title":"Effect of DNA methylation and chromatin structure on ITGAL expression","volume":"99","author":"Lu","year":"2002","journal-title":"Blood"},{"key":"2021100507420738100_keab095-B102","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/annrheumdis-2018-214323","article-title":"Hypomethylation of STAT1 and HLA-DRB1 is associated with type-I interferon-dependent HLA-DRB1 expression in lupus CD8+ T cells","volume":"78","author":"Miller","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021100507420738100_keab095-B103","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/rheumatology\/kew508","article-title":"TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus","volume":"56","author":"Zhao","year":"2017","journal-title":"Rheumatology"},{"key":"2021100507420738100_keab095-B104","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41467-018-02890-0","article-title":"IL-6\/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat Commun"},{"key":"2021100507420738100_keab095-B105","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.22646","article-title":"Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus","volume":"56","author":"Dieker","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B106","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molimm.2009.08.009","article-title":"Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies","volume":"47","author":"van Bavel","year":"2009","journal-title":"Mol Immunol"},{"key":"2021100507420738100_keab095-B107","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1074\/jbc.M801275200","article-title":"Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice","volume":"283","author":"Lu","year":"2008","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B108","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/pr050188r","article-title":"Resetting the epigenetic histone code in the MRL-lpr\/lpr mouse model of lupus by histone deacetylase inhibition","volume":"4","author":"Garcia","year":"2005","journal-title":"J Proteome Res"},{"key":"2021100507420738100_keab095-B109","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1189\/jlb.0708401","article-title":"Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo","volume":"84","author":"Bosisio","year":"2008","journal-title":"J Leukoc Biol"},{"key":"2021100507420738100_keab095-B110","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1073\/pnas.051507098","article-title":"Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells","volume":"98","author":"Mishra","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021100507420738100_keab095-B111","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J Clin Invest"},{"key":"2021100507420738100_keab095-B112","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcb.10160","article-title":"Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling","volume":"85","author":"Nambiar","year":"2002","journal-title":"J Cell Biochem"},{"key":"2021100507420738100_keab095-B113","doi-asserted-by":"crossref","first-page":"28833","DOI":"10.1074\/jbc.M111.233932","article-title":"Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity","volume":"286","author":"Yan","year":"2011","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B114","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2014.01.002","article-title":"Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo","volume":"151","author":"Regna","year":"2014","journal-title":"Clin Immunol"},{"key":"2021100507420738100_keab095-B115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","article-title":"The CD38\/NAD\/SIRTUIN1\/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections","volume":"30","author":"Katsuyama","year":"2020","journal-title":"Cell Rep"},{"key":"2021100507420738100_keab095-B116","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat Med"},{"key":"2021100507420738100_keab095-B117","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2021100507420738100_keab095-B118","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1074\/jbc.M109.091660","article-title":"Alternative splicing factor\/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex","volume":"285","author":"Moulton","year":"2010","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B119","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1074\/jbc.M113.518662","article-title":"Ubiquitination regulates expression of the serine\/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells","volume":"289","author":"Moulton","year":"2014","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/art.10978","article-title":"Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus","volume":"48","author":"Jury","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/357161a0","article-title":"Profound block in thymocyte development in mice lacking p56lck","volume":"357","author":"Molina","year":"1992","journal-title":"Nature"},{"key":"2021100507420738100_keab095-B122","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1073\/pnas.062055999","article-title":"Negative regulation of Lck by Cbl ubiquitin ligase","volume":"99","author":"Rao","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021100507420738100_keab095-B123","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1074\/jbc.M110002200","article-title":"The Lck SH3 domain negatively regulates localization to lipid rafts through an interaction with c-Cbl","volume":"277","author":"Hawash","year":"2002","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B124","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbamcr.2005.08.009","article-title":"Evidences for ubiquitination and intracellular trafficking of LAT, the linker of activated T cells","volume":"1746","author":"Brignatz","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"2021100507420738100_keab095-B125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-065X.2009.00840.x","article-title":"Endocytic events in TCR signaling: focus on adapters in microclusters","volume":"232","author":"Balagopalan","year":"2009","journal-title":"Immunol Rev"},{"key":"2021100507420738100_keab095-B126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.immunol.22.012703.104813","article-title":"Ubiquitin ligases and the immune response","volume":"22","author":"Liu","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"2021100507420738100_keab095-B127","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35003228","article-title":"Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b","volume":"403","author":"Bachmaier","year":"2000","journal-title":"Nature"},{"key":"2021100507420738100_keab095-B128","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.4049\/jimmunol.165.11.6627","article-title":"Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells","volume":"165","author":"Yi","year":"2000","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B129","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/art.37833","article-title":"Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus","volume":"65","author":"Gomez-Martin","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021100507420738100_keab095-B130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fonc.2015.00058","article-title":"Modulation of Immune Cell Functions by the E3 Ligase Cbl-b","volume":"5","author":"Lutz-Nicoladoni","year":"2015","journal-title":"Front Oncol"},{"key":"2021100507420738100_keab095-B131","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.celrep.2012.04.008","article-title":"E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity","volume":"1","author":"Guo","year":"2012","journal-title":"Cell Rep"},{"key":"2021100507420738100_keab095-B132","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4049\/jimmunol.176.3.1316","article-title":"Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo","volume":"176","author":"Wohlfert","year":"2006","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/cei.13054","article-title":"Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus","volume":"191","author":"Romo-Tena","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2021100507420738100_keab095-B134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2016.06.003","article-title":"Transcription factor RFX1 is ubiquitinated by E3 ligase STUB1 in systemic lupus erythematosus","volume":"169","author":"Guo","year":"2016","journal-title":"Clin Immunol"},{"key":"2021100507420738100_keab095-B135","doi-asserted-by":"crossref","first-page":"29086","DOI":"10.1074\/jbc.M115.664573","article-title":"TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORgammat in Promoting IL-17A Expression","volume":"290","author":"Wang","year":"2015","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B136","doi-asserted-by":"crossref","first-page":"25546","DOI":"10.1074\/jbc.M114.565291","article-title":"The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor gammat (RORgammat) in Th17 cells","volume":"289","author":"Han","year":"2014","journal-title":"J Biol Chem"},{"key":"2021100507420738100_keab095-B137","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.4049\/jimmunol.1401451","article-title":"Cutting edge: ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORgammat","volume":"194","author":"Yang","year":"2015","journal-title":"J Immunol"},{"key":"2021100507420738100_keab095-B138","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3892\/mmr.2017.6819","article-title":"USP7 is associated with greater disease activity in systemic lupus erythematosus via stabilization of the IFNalpha receptor","volume":"16","author":"Yu","year":"2017","journal-title":"Mol Med Rep"},{"key":"2021100507420738100_keab095-B139","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molcel.2005.02.013","article-title":"GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7","volume":"17","author":"van der Knaap","year":"2005","journal-title":"Mol Cell"},{"key":"2021100507420738100_keab095-B140","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"2021100507420738100_keab095-B141","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","article-title":"Sumoylation: a regulatory protein modification in health and disease","volume":"82","author":"Flotho","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"2021100507420738100_keab095-B142","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molcel.2018.07.027","article-title":"SUMO-mediated regulation of nuclear functions and signaling processes","volume":"71","author":"Zhao","year":"2018","journal-title":"Mol Cell"},{"key":"2021100507420738100_keab095-B143","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/ni.3259","article-title":"TCR-induced sumoylation of the kinase PKC-\u03b8 controls T cell synapse organization and T cell activation","volume":"16","author":"Wang","year":"2015","journal-title":"Nat Immunol"},{"key":"2021100507420738100_keab095-B144","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cellsig.2015.03.001","article-title":"SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8+ T cells in mice","volume":"27","author":"Won","year":"2015","journal-title":"Cell Signal"},{"key":"2021100507420738100_keab095-B145","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.celrep.2016.06.056","article-title":"Protein SUMOylation is required for regulatory T cell expansion and function","volume":"16","author":"Ding","year":"2016","journal-title":"Cell Rep"},{"key":"2021100507420738100_keab095-B146","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/s41467-018-05676-6","article-title":"SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation","volume":"9","author":"Yu","year":"2018","journal-title":"Nat Commun"},{"key":"2021100507420738100_keab095-B147","article-title":"T cell receptor (TCR)-induced PLC-\u03b31 sumoylation via PIASx\u03b2 and PIAS3 SUMO E3 ligases regulates the microcluster assembly and physiological function of PLC-\u03b31","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B148","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fimmu.2018.00611","article-title":"Gender bias in human systemic lupus erythematosus: a problem of steroid receptor action?","volume":"9","author":"Rider","year":"2018","journal-title":"Front Immunol"},{"key":"2021100507420738100_keab095-B149","doi-asserted-by":"crossref","first-page":"e1006156","DOI":"10.1371\/journal.ppat.1006156","article-title":"SENP7 Potentiates cGAS Activation by Relieving SUMO-Mediated Inhibition of Cytosolic DNA Sensing","volume":"13","author":"Cui","year":"2017","journal-title":"PLoS Pathog"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab095\/36149362\/keab095.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2502\/40508569\/keab095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2502\/40508569\/keab095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T04:04:27Z","timestamp":1697688267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/2502\/6123790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":149,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3,10]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab095","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,3,10]]}}}